Researchers
-
Cesar Diaz Return
Clinical research in Rheumatology
-
Dacia Cerdá Gabaroi
Clinical research in Rheumatology
Phd -
Daniel Roig Vilaseca
Clinical research in Rheumatology
Phd -
Delia Reina Sanz
Clinical research in Rheumatology
-
Marina Gonzalez
Clinical research in Rheumatology
-
Montserrat Girabent Farrés
Clinical research in Rheumatology
-
Park Hye Sang
Clinical research in Rheumatology
-
Paula Estrada
Clinical research in Rheumatology
-
Ramón Figuls
Clinical research in Rheumatology
-
Sergio Heredia
Clinical research in Rheumatology
-
Silvia Garcia Diaz
Clinical research in Rheumatology
-
Vanessa Andrea Navarro Angeles
Clinical research in Rheumatology
Contact the group
Form
Projects
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Development and validation of an ultrasound index for disease activity in rheumatoid arthritis for use in clinical practice
-
DISTRICT ATTORNEY:
Catalan Society of Rheumatology
-
TYPE E:
PINE TREE
-
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Randomized, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy and safety of UCB5857 over 12 weeks in patients with primary Sjögren's syndrome
-
DISTRICT ATTORNEY:
UCB Celltech
-
TYPE E:
RD2015
-
Clinical research in Rheumatology
Researcher
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Phase III, multicenter, randomized, double-blind, placebo-controlled study of subcutaneous secukinumab (150 mg and 300 mg) in prefilled syringes to demonstrate efficacy (including inhibition of structural damage), safety, and tolerability up to 2 years in patients with active psoriatic arthritis (FUTURE 5)
-
DISTRICT ATTORNEY:
Novartis Pharmaceutica SA
-
TYPE E:
RD2004
-
Clinical research in Rheumatology
Researcher
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Non-interventional study to evaluate the effectiveness of certolizumab pegol in patients with axial spondyloarthritis in daily practice
-
DISTRICT ATTORNEY:
UCB Biopharma SPRL.
-
TYPE E:
EPA
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Non-interventional study to evaluate the effectiveness of certolizumab pegol in patients with axial spondyloarthritis in daily practice
-
DISTRICT ATTORNEY:
UCB Biopharma SPRL.
-
TYPE E:
EPA
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
Phase III, multicenter, randomized, double-blind, placebo-controlled study of subcutaneous secukinumab (150 mg and 300 mg) in prefilled syringes to demonstrate efficacy (including inhibition of structural damage), safety, and tolerability up to 2 years in patients with active psoriatic arthritis (FUTURE 5)
-
DISTRICT ATTORNEY:
Novartis Pharmaceutica SA
-
TYPE E:
RD2004
-
Clinical research in Rheumatology
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Randomized clinical trial on the prevention of radiological progression with zoledronic acid in patients with early rheumatoid arthritis and low disease activity,
-
DISTRICT ATTORNEY:
Dr. Carmen Gómez (University Hospital of Bellvitge)
-
TYPE E:
RD2004
-
Clinical research in Rheumatology
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
ASCORE study on long-term experience with abatacept sc in routine medical practice,
-
DISTRICT ATTORNEY:
Bristol- Myres Squibb Research and Development
-
TYPE E:
EPA
-
Clinical research in Rheumatology
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Phase IV trial to evaluate the effect of residual inflammation assessed by means of imaging studies, drug concentrations and patient characteristics, in the result of the gradual reduction of the dose of adalimumab in patients with rheumatoid arthritis in clinical remission (PREDICTRA Study)
-
DISTRICT ATTORNEY:
AbbVie Deutschland GmbH & Co. KG (AbbVie)
-
TYPE E:
RD2004
-
Clinical research in Rheumatology
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Pharmacokinetic/pharmacodynamic study of anti-TNF drugs (Etanercept, Adalimumab and Infliximab) in patients with rheumatoid arthritis,
-
DISTRICT ATTORNEY:
Bellvitge University Hospital - Pharmacy Service
-
TYPE E:
EPA
Lines of action
- Rheumatoid arthritis and biological therapies
- Osteoporosis and bone metabolism
- Connectivopathies and autoimmune diseases
- Periungual capillaroscopy
- Joint ultrasound
- Degenerative pathology of the musculoskeletal system
- Spondyloarthropathies
